Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
He argues that sponsors should be challenging carriers now on their strategy for upcoming generics and ultra generics - including how they will use tools such as price listing agreements, plan design, tiered formularies, maximum allowable cost and step therapy - and making sure those strategies are explicitly designed so that savings are captured quickly and flow directly back to the plan
The populations of interest were patients with T2D who received a second line treatment (and had MET as background therapy) and, separately, patients who received a third line treatment (and had metformin + SU as background therapy)
Published 2023 Apr 12
These policies exist to protect your safety, ensure appropriate clinical monitoring, and meet the documentation requirements that coverage programs (including the Bridge) require
